Cinctive Capital Management LP Bristol Myers Squibb CO Transaction History

Cinctive Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $16.2 Million - $17.6 Million	-261,083 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $2.41 Million - $2.71 Million	40,537 Added 18.38%	261,083 $16.5 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.48 Million - $1.68 Million	25,703 Added 13.19%	220,546 $13.7 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $2.52 Million - $2.79 Million	43,839 Added 29.03%	194,843 $11.7 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $2.87 Million - $3.35 Million	52,318 Added 53.01%	151,004 $8.88 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.21 Million - $1.76 Million	-26,114 Reduced 20.92%	98,686 $5.5 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $6.14 Million - $8.01 Million	124,800 New	124,800 $8.01 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.